Synthetic Genomics, Plenus Form New Company to Leverage Genomics for Agricultural Applications | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and Plenus today announced the formation of a new firm, Agradis, to develop and commercialize products that leverage new technologies in genomics and plant breeding.

The companies also announced Agradis has raised $20 million in a Series A financing round to establish a corporate infrastructure and to support product development and commercialization.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.